| | |
| Clinical data | |
|---|---|
| Other names | 4-Hydroxy-19-nortestosterone; 4,17β-Dihydroxyestr-4-en-3-one; 19-Norandrost-4-ene-4,17β-diol-3-one |
| Routes of administration | Intramuscular injection (as oxabolone cipionate) |
| Drug class | Androgen; Anabolic steroid |
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.022.920 |
| Chemical and physical data | |
| Formula | C18H26O3 |
| Molar mass | 290.403 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Oxabolone is a synthetic anabolic-androgenic steroid (AAS) of the nandrolone (19-nortestosterone) group which was never marketed. [1] [2] [3] It can be formulated as the cipionate ester prodrug oxabolone cipionate, which, in contrast, has been marketed for medical use. [1] [2] [3]
Oxabolone is on the World Anti-Doping Agency's list of prohibited substances, [4] and is therefore banned from use in most major sports.
The 17α-methylated analogue of oxabolone is methylhydroxynandrolone (4-hydroxy-17α-methyl-19-nortestosterone) and the 17α- and 19-methylated derivative of oxabolone is oxymesterone (4-hydroxy-17α-methyltestosterone). [1] [2] [3]